Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer--A retrospective study of ctDNA.

Zhang, Xuefei; Zhang, Youguo; Zhang, Shanli; Wang, Sha; Yang, Peng; Liu, Changhong

Zhang, Xuefei; Zhang, Youguo; Zhang, Shanli; Wang, Sha; Yang, Peng; Liu, Changhong.

Afiliação

Zhang X; Department of Thoracic Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zhang Y; Department of Thoracic Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zhang S; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Wang S; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Yang P; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Liu C; Department of Thoracic Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.

Front Oncol ; 13: 1098128, 2023.

Article em En | MEDLINE | ID: mdl-37091156

Palavras-chave

NSCLC1; ctDNA2; molecular residual disease (MRD)3; postoperative 4; recurrence risk 5

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google